Stockreport

Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial

Kiromic BioPharma, Inc.  (KRBP) 
PDF Third Patient Enrolled in Deltacel-01 Completes Treatment HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) announces that [Read more]